Lead: Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients

episode

This Week in Addiction Medicine from ASAM not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

TELL ME SOMETHING GOOD (THURS) Amy Avoided Murder! + Which Show Member Got An Office? 43 min · 24 Sep 2026 · The Bobby Bones Show

This Boy Scout Leader is Creepy // The John Getrue Murder Story 8 min · 24 Sep 2026 · Ray William Johnson: True Story Podcast

What’s going to happen to interest rates? And what it means for mortgages, savings & more! 1h 8m · 24 Sep 2026 · The Martin Lewis Podcast

Dan and His Inner Monologue Come to Blows | Postgame Show 13 min · 24 Sep 2026 · The Dan Le Batard Show

NPR News: 09-24-2026 12PM EDT 5 min · 24 Sep 2026 · NPR News Now

Your Turn -- It's a September Ask Me Anything, Plus the Random Ranter 51 min · 24 Sep 2026 · The Bridge with Peter Mansbridge

Report any issue

Source

Recorded19 Sep 2023

Publisherfeed.podbean.com ↗

Handlerec:607975

Show notes

Lead Story: Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients JAMA Network Open In this cohort study of 537 patients, all patients with novel potent opioid (NPO) overdose presented with opioid overdose symptoms and received multiple doses of naloxone. Compared with fentanyl overdose, patients with NPO overdose had a higher number of naloxone doses administered in-hospital; metonitazene overdose was associated with cardiac arrest and more naloxone doses overall. These findings suggest that NPOs may have a higher potency than fentanyl due to the observed naloxone administration in the clinical setting of overdose. Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in